Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: 2010

View all 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Archive
 

Recommendations - 2010

Sexually Transmitted Diseases Treatment Guidelines, 2010
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110
HTML  |  PDF
 
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
 
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
 
Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Source: MMWR, August 13, 2010; 59(31):989-92
HTML  |  PDF
 
Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, August 6, 2010; 59(rr08):1-62
HTML  |  PDF
 
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, July 30, 2010; 59(RR07):1-27
HTML  |  PDF
 
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010; 59(rr06):1-36
HTML  |  PDF
 
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
 
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486
HTML  |  PDF
 
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010; 59(02):1-9
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):273
HTML  |  PDF
 
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
 
Japanese Encephalitis Vaccines
Source: MMWR, March 12, 2010; 59(01):1-27
HTML  |  PDF
 
Recommended Adult Immunization Schedule--United States, 2010
Source: MMWR, January 15, 2010; 59(01:1-4)
HTML  |  PDF
 
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--United States, 2010
Source: MMWR, January 8, 2010; 58(51&52):1-4
HTML  |  PDF
This page was reviewed on December 16, 2010
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.